As of March 23, 2026, Coherus Oncology's top three insider holders are Dennis M Lanfear (President Ceo, 1.05Mn shares), Dennis M Lanfear (President Ceo, 432.68K shares), Bryan J Mcmichael (Chief Financial Officer, 133.74K shares).
| Holder | Position | Shares (Direct) | Shares (Indirect) | Report Date |
|---|---|---|---|---|
| Dennis M Lanfear | President Ceo | 1,048,235 | 0 | 26 Jan, 2026 |
| Dennis M Lanfear | President Ceo | 0 | 432,684 | 04 Jan, 2023 |
| Bryan J Mcmichael | Chief Financial Officer | 133,736 | 0 | 26 Jan, 2026 |
| Vincent R Anicetti | Chief Operating Officer | 124,790 | 0 | 08 Jul, 2021 |
| Vladimir Vexler | Chief Scientific Officer | 116,361 | 0 | 04 Apr, 2023 |
| Paul Reider | Chief Commercial Officer | 82,069 | 0 | 22 Jan, 2025 |
| Mcdavid Stilwell | Chief Financial Officer | 75,305 | 0 | 03 Jan, 2024 |
* Please note that the shares above only reflect shares from the fund portfolio and the institutional portfolio. Shares from the personal portfolio are excluded from this Institutional Ownership Page. See these insiders' latest transactions here on Insider Page.
| Transaction Date | Insider Name | Security Class | Transaction Type | Shares Traded | Price | Shares Remaining | Ownership | Code |
|---|---|---|---|---|---|---|---|---|
| 23 Jan, 2026 | Dennis M Lanfear | Common Stock | A | 375,000 | $0.00 | 1,048,235 | D | A |
| 22 Jan, 2026 | Bryan J Mcmichael | Common Stock | A | 112,500 | $0.00 | 133,736 | D | A |
| 22 Jan, 2026 | Bryan J Mcmichael | Stock Option (Right to Buy) | A | 225,000 | $0.00 | 225,000 | D | A |
| 23 Jan, 2026 | Dennis M Lanfear | Stock Option (Right to Buy) | A | 750,000 | $0.00 | 750,000 | D | A |
| 20 Jan, 2026 | Bryan J Mcmichael | Common Stock | D | 1,715 | $1.55 | 21,236 | D | F |
| 20 Jan, 2026 | Dennis M Lanfear | Common Stock | D | 11,839 | $1.55 | 673,235 | D | F |
| 12 Jun, 2025 | Mats Wahlstrom | Stock Option (Right to Buy) | A | 112,000 | $0.00 | 112,000 | D | A |
| 12 Jun, 2025 | Michael Lee Ryan | Stock Option (Right to Buy) | A | 112,000 | $0.00 | 112,000 | D | A |
| 12 Jun, 2025 | Charles W. Newton | Stock Option (Right to Buy) | A | 112,000 | $0.00 | 112,000 | D | A |
| 12 Jun, 2025 | Georgia Erbez | Stock Option (Right to Buy) | A | 112,000 | $0.00 | 112,000 | D | A |
| 12 Jun, 2025 | Jill O'Donnell-Tormey | Stock Option (Right to Buy) | A | 112,000 | $0.00 | 112,000 | D | A |
| 12 Jun, 2025 | Rita A Karachun | Stock Option (Right to Buy) | A | 112,000 | $0.00 | 112,000 | D | A |
| 12 Jun, 2025 | Ali J. Satvat | Stock Option (Right to Buy) | A | 112,000 | $0.00 | 112,000 | D | A |
| 12 Jun, 2025 | Lee Nisley Newcomer | Stock Option (Right to Buy) | A | 112,000 | $0.00 | 112,000 | D | A |
| 23 May, 2025 | Mats Wahlstrom | Common Stock | D | 99,988 | $0.74 | 0 | I | S |
| 07 May, 2025 | Bryan J Mcmichael | Stock Option (Right to Buy) | A | 200,000 | $0.00 | 200,000 | D | A |
| 07 May, 2025 | Dennis M Lanfear | Stock Option (Right to Buy) | A | 375,000 | $0.00 | 375,000 | D | A |
| 20 Jan, 2025 | Dennis M Lanfear | Common Stock | D | 11,810 | $1.39 | 685,074 | D | F |
| 20 Jan, 2025 | Paul Reider | Common Stock | D | 4,858 | $1.39 | 82,069 | D | F |
| 20 Jan, 2025 | Bryan J Mcmichael | Common Stock | D | 1,711 | $1.39 | 22,951 | D | F |